Tapewire

Nasdaq · USD

ANNX

Annexon, Inc.

Export transactions ↓
Tapewire entity
5011
SEC CIK
0001528115
Parsed reports
206

Last 12 months

Inside the activity.

13 purchase rows · 10 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202550
Dec 202530
Jan 202600
Feb 202605
Mar 202615
Apr 202610
May 202620
Jun 202600
Jul 202600
Aug 202600
Sep 202610
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 30, 2025 Filed Jul 1, 2025 20:55 UTC PurchaseCommon Stock 4,115 $2.46 $10,122.90
Disclosure

SEC source: 0001415889-25-018724 · form4-07012025_080710.xml · nonDerivative · entry 1

Carson William H. · CIK 0001824280 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 29,715

F1 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted March 17, 2025.

F2 · price: This transaction was executed in multiple trades in prices ranging from $2.45 to $2.47, inclusive. The price reported in Column 4 above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each respective price within the range set forth in this footnote.

Read SEC document
June 05, 2025 Filed Jun 9, 2025 20:30 UTC GrantStock Option (Right to Buy) · Derivative 55,000 $0.00 Strike: $2.55 $0.00
Disclosure

SEC source: 0001415889-25-016275 · form4-06092025_080622.xml · derivative · entry 1

WIGGANS THOMAS G · CIK 0001208907 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,000

Underlying: Common Stock · 55,000 shares

Expires 2035-06-05

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of June 5, 2025 or (ii) the next Annual Meeting following June 5, 2025, subject to Reporting Person's continuous service as a director until such vesting date.

Read SEC document
June 05, 2025 Filed Jun 9, 2025 20:27 UTC
Satter Muneer ADirector · 10% owner
GrantStock Option (Right to Buy) · Derivative 55,000 $0.00 Strike: $2.55 $0.00
Disclosure

SEC source: 0001415889-25-016267 · form4-06092025_080602.xml · derivative · entry 1

Satter Muneer A · CIK 0001315797 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,000

Underlying: Common Stock · 55,000 shares

Expires 2035-06-05

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of June 5, 2025 or (ii) the next Annual Meeting following June 5, 2025, subject to Reporting Person's continuous service as a director until such vesting date.

Read SEC document
June 05, 2025 Filed Jun 9, 2025 20:17 UTC GrantStock Option (Right to Buy) · Derivative 55,000 $0.00 Strike: $2.55 $0.00
Disclosure

SEC source: 0001415889-25-016243 · form4-06092025_080648.xml · derivative · entry 1

JONES WILLIAM A JR · CIK 0001373097 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,000

Underlying: Common Stock · 55,000 shares

Expires 2035-06-05

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of June 5, 2025 or (ii) the next Annual Meeting following June 5, 2025, subject to Reporting Person's continuous service as a director until such vesting date.

Read SEC document
June 05, 2025 Filed Jun 9, 2025 20:24 UTC GrantStock Option (Right to Buy) · Derivative 55,000 $0.00 Strike: $2.55 $0.00
Disclosure

SEC source: 0001415889-25-016263 · form4-06092025_080605.xml · derivative · entry 1

Waddill William D. · CIK 0001553338 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,000

Underlying: Common Stock · 55,000 shares

Expires 2035-06-05

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of June 5, 2025 or (ii) the next Annual Meeting following June 5, 2025, subject to Reporting Person's continuous service as a director until such vesting date.

Read SEC document
June 05, 2025 Filed Jun 9, 2025 20:22 UTC GrantStock Option (Right to Buy) · Derivative 55,000 $0.00 Strike: $2.55 $0.00
Disclosure

SEC source: 0001415889-25-016258 · form4-06092025_080607.xml · derivative · entry 1

Carson William H. · CIK 0001824280 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,000

Underlying: Common Stock · 55,000 shares

Expires 2035-06-05

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of June 5, 2025 or (ii) the next Annual Meeting following June 5, 2025, subject to Reporting Person's continuous service as a director until such vesting date.

Read SEC document
June 05, 2025 Filed Jun 9, 2025 20:20 UTC
Choi JungDirector
GrantStock Option (Right to Buy) · Derivative 55,000 $0.00 Strike: $2.55 $0.00
Disclosure

SEC source: 0001415889-25-016245 · form4-06092025_080652.xml · derivative · entry 1

Choi Jung · CIK 0001650126 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,000

Underlying: Common Stock · 55,000 shares

Expires 2035-06-05

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of June 5, 2025 or (ii) the next Annual Meeting following June 5, 2025, subject to Reporting Person's continuous service as a director until such vesting date.

Read SEC document
June 05, 2025 Filed Jun 9, 2025 20:16 UTC GrantStock Option (Right to Buy) · Derivative 55,000 $0.00 Strike: $2.55 $0.00
Disclosure

SEC source: 0001415889-25-016240 · form4-06092025_080604.xml · derivative · entry 1

Cockroft Bettina M. · CIK 0001900452 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,000

Underlying: Common Stock · 55,000 shares

Expires 2035-06-05

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of June 5, 2025 or (ii) the next Annual Meeting following June 5, 2025, subject to Reporting Person's continuous service as a director until such vesting date.

Read SEC document
February 27, 2025 Filed Mar 3, 2025 16:45 UTC
Overdorf MichaelEVP & CHIEF BUSINESS OFFICER
GrantStock Option (Right to Buy) · Derivative 272,575 $0.00 Strike: $2.50 $0.00
Disclosure

SEC source: 0001415889-25-006190 · form4-03032025_090336.xml · derivative · entry 2

Overdorf Michael · CIK 0001818522 · EVP & CHIEF BUSINESS OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 272,575

Underlying: Common Stock · 272,575 shares

Expires 2034-02-27

F2 · derivative.exercise_date: 1/48th of the shares subject to the option vest on each monthly anniversary measured from February 27, 2025 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Read SEC document
February 27, 2025 Filed Mar 3, 2025 16:50 UTC
Love DouglasDirector · PRESIDENT AND CEO
GrantStock Option (Right to Buy) · Derivative 1,300,000 $0.00 Strike: $2.50 $0.00
Disclosure

SEC source: 0001415889-25-006192 · form4-03032025_090314.xml · derivative · entry 1

Love Douglas · CIK 0001818520 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,300,000

Underlying: Common Stock · 1,300,000 shares

Expires 2034-02-27

F1 · derivative.exercise_date: 1/48th of the shares subject to the option vest on each monthly anniversary measured from February 27, 2025 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Read SEC document
February 27, 2025 Filed Mar 3, 2025 21:48 UTC
Yednock TedEVP & CHIEF INNOVATION OFFICER
GrantStock Option (Right to Buy) · Derivative 272,575 $0.00 Strike: $2.50 $0.00
Disclosure

SEC source: 0001415889-25-006191 · form4-03032025_090340.xml · derivative · entry 2

Yednock Ted · CIK 0001818525 · EVP & CHIEF INNOVATION OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 272,575

Underlying: Common Stock · 272,575 shares

Expires 2034-02-27

F2 · derivative.exercise_date: 1/48th of the shares subject to the option vest on each monthly anniversary measured from February 27, 2025 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Read SEC document
February 27, 2025 Filed Mar 3, 2025 21:52 UTC
Lew JenniferEVP & CHIEF FINANCIAL OFFICER
GrantStock Option (Right to Buy) · Derivative 272,575 $0.00 Strike: $2.50 $0.00
Disclosure

SEC source: 0001415889-25-006193 · form4-03032025_090309.xml · derivative · entry 2

Lew Jennifer · CIK 0001465994 · EVP & CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 272,575

Underlying: Common Stock · 272,575 shares

Expires 2034-02-27

F2 · derivative.exercise_date: 1/48th of the shares subject to the option vest on each monthly anniversary measured from February 27, 2025 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Read SEC document
February 27, 2025 Filed Mar 3, 2025 21:56 UTC
ARTIS DEAN RICHARDEVP & CHIEF SCIENTIFIC OFFICER
GrantStock Option (Right to Buy) · Derivative 272,575 $0.00 Strike: $2.50 $0.00
Disclosure

SEC source: 0001415889-25-006196 · form4-03032025_090332.xml · derivative · entry 2

ARTIS DEAN RICHARD · CIK 0001958523 · EVP & CHIEF SCIENTIFIC OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 272,575

Underlying: Common Stock · 272,575 shares

Expires 2034-02-27

F2 · derivative.exercise_date: 1/48th of the shares subject to the option vest on each monthly anniversary measured from February 27, 2025 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Read SEC document
February 27, 2025 Filed Mar 3, 2025 21:55 UTC
Dananberg JamieCHIEF MEDICAL OFFICER
GrantStock Option (Right to Buy) · Derivative 228,225 $0.00 Strike: $2.50 $0.00
Disclosure

SEC source: 0001415889-25-006195 · form4-03032025_090331.xml · derivative · entry 2

Dananberg Jamie · CIK 0001734424 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 228,225

Underlying: Common Stock · 228,225 shares

Expires 2034-02-27

F2 · derivative.exercise_date: 1/48th of the shares subject to the option vest on each monthly anniversary measured from February 27, 2025 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Read SEC document
February 18, 2025 Filed Feb 20, 2025 16:49 UTC
Overdorf MichaelEVP & CHIEF BUSINESS OFFICER
SaleCommon Stock 6,618 $2.95 $19,523.10
Disclosure

SEC source: 0001415889-25-004887 · form4-02202025_090246.xml · nonDerivative · entry 1

Overdorf Michael · CIK 0001818522 · EVP & CHIEF BUSINESS OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 86,579

F1 · kind: The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs").

F2 · price: This transaction was executed in multiple trades in prices ranging from $2.85 to $3.12, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
February 18, 2025 Filed Feb 20, 2025 21:51 UTC
Yednock TedEVP & CHIEF INNOVATION OFFICER
SaleCommon Stock 8,345 $2.91 $24,283.95
Disclosure

SEC source: 0001415889-25-004888 · form4-02202025_090206.xml · nonDerivative · entry 1

Yednock Ted · CIK 0001818525 · EVP & CHIEF INNOVATION OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 61,237

F1 · kind: The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs").

F2 · price: This transaction was executed in multiple trades in prices ranging from $2.77 to $3.1376, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
February 18, 2025 Filed Feb 20, 2025 21:48 UTC
Lew JenniferEVP & CHIEF FINANCIAL OFFICER
SaleCommon Stock 6,912 $2.92 $20,183.04
Disclosure

SEC source: 0001415889-25-004886 · form4-02202025_090202.xml · nonDerivative · entry 1

Lew Jennifer · CIK 0001465994 · EVP & CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 77,770

F1 · kind: The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs").

F2 · price: This transaction was executed in multiple trades in prices ranging from $2.79 to $3.12, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
February 18, 2025 Filed Feb 20, 2025 21:52 UTC
ARTIS DEAN RICHARDEVP & CHIEF SCIENTIFIC OFFICER
SaleCommon Stock 5,515 $2.97 $16,379.55
Disclosure

SEC source: 0001415889-25-004889 · form4-02202025_090227.xml · nonDerivative · entry 1

ARTIS DEAN RICHARD · CIK 0001958523 · EVP & CHIEF SCIENTIFIC OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 83,814

F1 · kind: The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs").

F2 · price: This transaction was executed in multiple trades in prices ranging from $2.86 to $3.1376, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
February 18, 2025 Filed Feb 20, 2025 21:54 UTC
Dananberg JamieCHIEF MEDICAL OFFICER
SaleCommon Stock 5,521 $2.96 $16,342.16
Disclosure

SEC source: 0001415889-25-004891 · form4-02202025_090205.xml · nonDerivative · entry 1

Dananberg Jamie · CIK 0001734424 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,479

F1 · kind: The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs").

F2 · price: This transaction was executed in multiple trades in prices ranging from $2.855 to $3.12, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 16:30 UTC
Overdorf MichaelEVP & CHIEF BUSINESS OFFICER
SaleCommon Stock 1,425 $2.99 $4,260.75
Disclosure

SEC source: 0001415889-25-004431 · form4-02182025_040201.xml · nonDerivative · entry 1

Overdorf Michael · CIK 0001818522 · EVP & CHIEF BUSINESS OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 93,197

F1 · kind: The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs").

F2 · price: This transaction was executed in multiple trades in prices ranging from $2.90 to $3.02, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 16:30 UTC
Love DouglasDirector · PRESIDENT AND CEO
SaleCommon Stock 5,021 $2.95 $14,811.95
Disclosure

SEC source: 0001415889-25-004434 · form4-02182025_040207.xml · nonDerivative · entry 1

Love Douglas · CIK 0001818520 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 351,554

F1 · kind: The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs").

F2 · price: This transaction was executed in multiple trades in prices ranging from $2.87 to $3.0297, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 21:30 UTC
Yednock TedEVP & CHIEF INNOVATION OFFICER
SaleCommon Stock 1,783 $2.99 $5,331.17
Disclosure

SEC source: 0001415889-25-004432 · form4-02182025_040203.xml · nonDerivative · entry 1

Yednock Ted · CIK 0001818525 · EVP & CHIEF INNOVATION OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 69,582

F1 · kind: The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs").

F2 · price: This transaction was executed in multiple trades in prices ranging from $2.895 to $3.0297, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 21:30 UTC
Lew JenniferEVP & CHIEF FINANCIAL OFFICER
SaleCommon Stock 1,786 $2.98 $5,322.28
Disclosure

SEC source: 0001415889-25-004433 · form4-02182025_040205.xml · nonDerivative · entry 1

Lew Jennifer · CIK 0001465994 · EVP & CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 84,682

F1 · kind: The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs").

F2 · price: This transaction was executed in multiple trades in prices ranging from $2.89 to $3.015, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
January 09, 2025 Filed Jan 10, 2025 23:02 UTC GrantStock Option (Right to Buy) · Derivative 88,000 $0.00 Strike: $4.83 $0.00
Disclosure

SEC source: 0001415889-25-001308 · form4-01102025_110119.xml · derivative · entry 1

JONES WILLIAM A JR · CIK 0001373097 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 88,000

Underlying: Common Stock · 88,000 shares

Expires 2035-01-09

F1 · derivative.exercise_date: 1/36th of the shares subject to the option vest on each monthly anniversary measured from January 9, 2025 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the third anniversary of the Vesting Commencement Date.

Read SEC document
January 06, 2025 Filed Jan 8, 2025 17:58 UTC
Love DouglasDirector · PRESIDENT AND CEO
Exercise / conversionStock Option (Right to Buy) · Derivative 37,994 $0.00 Strike: $1.41 $0.00
Disclosure

SEC source: 0001415889-25-001149 · form4-01082025_100151.xml · derivative · entry 2

Love Douglas · CIK 0001818520 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 37,994 shares

Expires 2025-01-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable.

Read SEC document
January 06, 2025 Filed Jan 8, 2025 17:58 UTC
Love DouglasDirector · PRESIDENT AND CEO
Exercise / conversionCommon Stock 37,994 $1.41 $53,556.34
Disclosure

SEC source: 0001415889-25-001149 · form4-01082025_100151.xml · nonDerivative · entry 1

Love Douglas · CIK 0001818520 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 356,575

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 5,514 shares acquired on May 15, 2024 and 2,497 shares acquired on November 15, 2024, pursuant to the Issuer's Employee Stock Purchase Plan.

Read SEC document
December 02, 2024 Filed Dec 4, 2024 23:12 UTC PurchaseCommon Stock 3,200 $5.33 $17,056.00
Disclosure

SEC source: 0001415889-24-028316 · form4-12042024_111242.xml · nonDerivative · entry 1

Carson William H. · CIK 0001824280 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 25,600

F1 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted January 4, 2024.

F2 · price: This transaction was executed in multiple trades in prices ranging from $5.25 to $5.53, inclusive. The price reported in Column 4 above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each respective price within the range set forth in this footnote.

Read SEC document
October 30, 2024 Filed Nov 1, 2024 16:15 UTC
Love DouglasDirector · PRESIDENT AND CEO
Exercise / conversionStock Option (Right to Buy) · Derivative 36,050 $0.00 Strike: $1.85 $0.00
Disclosure

SEC source: 0001415889-24-025902 · form4-11012024_041101.xml · derivative · entry 4

Love Douglas · CIK 0001818520 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 36,050 shares

Expires 2026-08-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable.

Read SEC document
October 30, 2024 Filed Nov 1, 2024 16:15 UTC
Love DouglasDirector · PRESIDENT AND CEO
Exercise / conversionStock Option (Right to Buy) · Derivative 78,399 $0.00 Strike: $1.85 $0.00
Disclosure

SEC source: 0001415889-24-025902 · form4-11012024_041101.xml · derivative · entry 3

Love Douglas · CIK 0001818520 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 78,399 shares

Expires 2026-08-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable.

Read SEC document
October 30, 2024 Filed Nov 1, 2024 16:15 UTC
Love DouglasDirector · PRESIDENT AND CEO
Exercise / conversionCommon Stock 36,050 $1.85 $66,696.11
Disclosure

SEC source: 0001415889-24-025902 · form4-11012024_041101.xml · nonDerivative · entry 2

Love Douglas · CIK 0001818520 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 310,570

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 30, 2024 Filed Nov 1, 2024 16:15 UTC
Love DouglasDirector · PRESIDENT AND CEO
Exercise / conversionCommon Stock 78,399 $1.85 $145,045.99
Disclosure

SEC source: 0001415889-24-025902 · form4-11012024_041101.xml · nonDerivative · entry 1

Love Douglas · CIK 0001818520 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 274,520

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 15, 2024 Filed Oct 17, 2024 21:09 UTC
Yednock TedEVP & CHIEF INNOVATION OFFICER
Exercise / conversionStock Option (Right to Buy) · Derivative 5,408 $0.00 Strike: $1.85 $0.00
Disclosure

SEC source: 0001415889-24-025382 · form4-10172024_091004.xml · derivative · entry 3

Yednock Ted · CIK 0001818525 · EVP & CHIEF INNOVATION OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 30,646

Underlying: Common Stock · 5,408 shares

Expires 2026-08-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable.

Read SEC document
October 15, 2024 Filed Oct 17, 2024 21:09 UTC
Yednock TedEVP & CHIEF INNOVATION OFFICER
SaleCommon Stock 5,408 $7.41 $40,073.28
Disclosure

SEC source: 0001415889-24-025382 · form4-10172024_091004.xml · nonDerivative · entry 2

Yednock Ted · CIK 0001818525 · EVP & CHIEF INNOVATION OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 71,365

F1 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted April 12, 2024.

Read SEC document
October 15, 2024 Filed Oct 17, 2024 21:09 UTC
Yednock TedEVP & CHIEF INNOVATION OFFICER
Exercise / conversionCommon Stock 5,408 $1.85 $10,005.34
Disclosure

SEC source: 0001415889-24-025382 · form4-10172024_091004.xml · nonDerivative · entry 1

Yednock Ted · CIK 0001818525 · EVP & CHIEF INNOVATION OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 76,773

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 01, 2024 Filed Oct 2, 2024 20:15 UTC PurchaseCommon Stock 3,200 $5.97 $19,104.00
Disclosure

SEC source: 0001415889-24-024384 · form4-10022024_041010.xml · nonDerivative · entry 1

Carson William H. · CIK 0001824280 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 22,400

F1 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted January 4, 2024.

F2 · price: This transaction was executed in multiple trades in prices ranging from $5.765 to $6.16, inclusive. The price reported in Column 4 above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each respective price within the range set forth in this footnote.

Read SEC document
September 19, 2024 Filed Sep 20, 2024 20:30 UTC
Yednock TedEVP & CHIEF INNOVATION OFFICER
SaleCommon Stock 4,500 $7.10 $31,950.00
Disclosure

SEC source: 0001415889-24-023771 · form4-09202024_040902.xml · nonDerivative · entry 1

Yednock Ted · CIK 0001818525 · EVP & CHIEF INNOVATION OFFICER

10b5-1 filing: Plan reported

Ownership: Indirect · By Spouse

Disclosed balance after: 0

F1 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted April 12, 2024.

Read SEC document
September 12, 2024 Filed Sep 16, 2024 20:30 UTC
Yednock TedEVP & CHIEF INNOVATION OFFICER
SaleCommon Stock 5,500 $6.16 $33,880.00
Disclosure

SEC source: 0001415889-24-023441 · form4-09162024_040901.xml · nonDerivative · entry 1

Yednock Ted · CIK 0001818525 · EVP & CHIEF INNOVATION OFFICER

10b5-1 filing: Plan reported

Ownership: Indirect · By Spouse

Disclosed balance after: 4,500

F1 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted April 12, 2024.

Read SEC document
September 05, 2024 Filed Sep 6, 2024 20:30 UTC
Yednock TedEVP & CHIEF INNOVATION OFFICER
SaleCommon Stock 5,500 $5.64 $31,020.00
Disclosure

SEC source: 0001415889-24-023018 · form4-09062024_040902.xml · nonDerivative · entry 1

Yednock Ted · CIK 0001818525 · EVP & CHIEF INNOVATION OFFICER

10b5-1 filing: Plan reported

Ownership: Indirect · By Spouse

Disclosed balance after: 10,000

F1 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted April 12, 2024.

Read SEC document
September 03, 2024 Filed Sep 4, 2024 20:34 UTC PurchaseCommon Stock 3,200 $5.48 $17,536.00
Disclosure

SEC source: 0001415889-24-022785 · form4-09042024_040906.xml · nonDerivative · entry 1

Carson William H. · CIK 0001824280 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 19,200

F1 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted January 4, 2024.

F2 · price: This transaction was executed in multiple trades in prices ranging from $5.38 to $5.70, inclusive. The price reported in Column 4 above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each respective price within the range set forth in this footnote.

Read SEC document
August 29, 2024 Filed Aug 30, 2024 22:00 UTC
Yednock TedEVP & CHIEF INNOVATION OFFICER
SaleCommon Stock 5,500 $5.95 $32,725.00
Disclosure

SEC source: 0001415889-24-022645 · form4-08302024_100809.xml · nonDerivative · entry 1

Yednock Ted · CIK 0001818525 · EVP & CHIEF INNOVATION OFFICER

10b5-1 filing: Plan reported

Ownership: Indirect · By Spouse

Disclosed balance after: 15,500

F1 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted April 12, 2024.

Read SEC document
August 01, 2024 Filed Aug 5, 2024 23:53 UTC PurchaseCommon Stock 3,200 $6.24 $19,968.00
Disclosure

SEC source: 0001415889-24-020789 · form4-08052024_110859.xml · nonDerivative · entry 1

Carson William H. · CIK 0001824280 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 16,000

F1 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted January 4, 2024.

F2 · price: This transaction was executed in multiple trades in prices ranging from $6.07 to $6.455, inclusive. The price reported in Column 4 above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each respective price within the range set forth in this footnote.

Read SEC document
July 15, 2024 Filed Jul 17, 2024 16:49 UTC
Overdorf MichaelEVP & CHIEF BUSINESS OFFICER
SaleCommon Stock 784 $6.02 $4,719.68
Disclosure

SEC source: 0001415889-24-019679 · form4-07172024_080750.xml · nonDerivative · entry 1

Overdorf Michael · CIK 0001818522 · EVP & CHIEF BUSINESS OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,622

F1 · kind: The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs").

F2 · price: This transaction was executed in multiple trades in prices ranging from $5.99 to $6.05, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

F3 · balance_after: Includes 9,765 shares acquired on May 15, 2024, pursuant to the Issuer's Employee Stock Purchase Plan.

Read SEC document
July 15, 2024 Filed Jul 17, 2024 20:46 UTC
Yednock TedEVP & CHIEF INNOVATION OFFICER
SaleCommon Stock 1,106 $6.02 $6,658.12
Disclosure

SEC source: 0001415889-24-019677 · form4-07172024_080745.xml · nonDerivative · entry 1

Yednock Ted · CIK 0001818525 · EVP & CHIEF INNOVATION OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,365

F1 · kind: The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs").

F2 · price: This transaction was executed in multiple trades in prices ranging from $5.97 to $6.04, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
July 15, 2024 Filed Jul 17, 2024 20:48 UTC
Lew JenniferEVP & CHIEF FINANCIAL OFFICER
SaleCommon Stock 1,104 $6.03 $6,657.12
Disclosure

SEC source: 0001415889-24-019678 · form4-07172024_080740.xml · nonDerivative · entry 1

Lew Jennifer · CIK 0001465994 · EVP & CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 86,468

F1 · kind: The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs").

F2 · price: This transaction was executed in multiple trades in prices ranging from $5.97 to $6.04, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

F3 · balance_after: Includes 5,514 shares acquired on May 15, 2024, pursuant to the Issuer's Employee Stock Purchase Plan.

Read SEC document
July 01, 2024 Filed Jul 2, 2024 21:43 UTC PurchaseCommon Stock 3,200 $5.00 $16,000.00
Disclosure

SEC source: 0001415889-24-018985 · form4-07022024_090733.xml · nonDerivative · entry 1

Carson William H. · CIK 0001824280 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 12,800

F1 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted January 4, 2024.

F2 · price: This transaction was executed in multiple trades in prices ranging from $4.83 to $5.145, inclusive. The price reported in Column 4 above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
June 05, 2024 Filed Jun 8, 2024 01:45 UTC GrantStock Option (Right to Buy) · Derivative 44,000 $0.00 Strike: $6.79 $0.00
Disclosure

SEC source: 0001415889-24-016111 · form4-06082024_010649.xml · derivative · entry 1

WIGGANS THOMAS G · CIK 0001208907 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,000

Underlying: Common Stock · 44,000 shares

Expires 2034-06-05

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of June 5, 2024 or (ii) the next Annual Meeting following June 5, 2024, subject to Reporting Person's continuous service as a director until such vesting date.

Read SEC document
June 05, 2024 Filed Jun 8, 2024 01:44 UTC
Satter Muneer ADirector · 10% owner
GrantStock Option (Right to Buy) · Derivative 44,000 $0.00 Strike: $6.79 $0.00
Disclosure

SEC source: 0001415889-24-016106 · form4-06082024_010634.xml · derivative · entry 1

Satter Muneer A · CIK 0001315797 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,000

Underlying: Common Stock · 44,000 shares

Expires 2034-06-05

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of June 5, 2024 or (ii) the next Annual Meeting following June 5, 2024, subject to Reporting Person's continuous service as a director until such vesting date.

Read SEC document
June 05, 2024 Filed Jun 8, 2024 01:43 UTC
Choi JungDirector
GrantStock Option (Right to Buy) · Derivative 44,000 $0.00 Strike: $6.79 $0.00
Disclosure

SEC source: 0001415889-24-016105 · form4-06082024_010637.xml · derivative · entry 1

Choi Jung · CIK 0001650126 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,000

Underlying: Common Stock · 44,000 shares

Expires 2034-06-05

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of June 5, 2024 or (ii) the next Annual Meeting following June 5, 2024, subject to Reporting Person's continuous service as a director until such vesting date.

Read SEC document
June 05, 2024 Filed Jun 8, 2024 01:42 UTC GrantStock Option (Right to Buy) · Derivative 44,000 $0.00 Strike: $6.79 $0.00
Disclosure

SEC source: 0001415889-24-016104 · form4-06082024_010625.xml · derivative · entry 1

Waddill William D. · CIK 0001553338 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,000

Underlying: Common Stock · 44,000 shares

Expires 2034-06-05

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of June 5, 2024 or (ii) the next Annual Meeting following June 5, 2024, subject to Reporting Person's continuous service as a director until such vesting date.

Read SEC document
June 05, 2024 Filed Jun 8, 2024 01:41 UTC GrantStock Option (Right to Buy) · Derivative 44,000 $0.00 Strike: $6.79 $0.00
Disclosure

SEC source: 0001415889-24-016103 · form4-06082024_010632.xml · derivative · entry 1

Carson William H. · CIK 0001824280 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,000

Underlying: Common Stock · 44,000 shares

Expires 2034-06-05

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of June 5, 2024 or (ii) the next Annual Meeting following June 5, 2024, subject to Reporting Person's continuous service as a director until such vesting date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.